ZhenGe Biotech, a China-based Contract Development and Manufacturing Organization (CDMO), has entered into a strategic partnership with NNIT, a Denmark-headquartered provider of digital life sciences solutions. Under the terms of the agreement, NNIT will support ZhenGe in developing a more reliable digitalization platform that offers full lifecycle digital solutions, from high-quality drug research and development to commercial manufacturing services. Financial details of the partnership were not disclosed.
ZhenGe Biotech’s Focus on Macromolecule Drugs and Digital Infrastructure
Founded in 2017, ZhenGe Biotech is dedicated to the macromolecule drug sector. The company has been consulting with NNIT to implement and validate its Laboratory Information Management System (LIMS), a critical component of its digitalization infrastructure that encompasses three QC laboratories. This collaboration is set to enhance ZhenGe’s capabilities in GMP compliant lab operations, GMP compliant manufacturing, quality control, and computational system validation.
Expanding Collaboration for Future Growth
Looking ahead, ZhenGe Biotech and NNIT will continue their collaboration to ensure that all aspects of the drug development and manufacturing process are in line with Good Manufacturing Practice (GMP) standards. This partnership is a significant step for ZhenGe Biotech as it aims to leverage digital solutions to improve efficiency and reliability in the pharmaceutical industry.-Fineline Info & Tech
